HRT & MENOPAUSE

HRT Explained: Benefits, Risks & Who It May Suit

Hormone replacement therapy (HRT) can be an effective treatment for symptoms of perimenopause and menopause, but it is not a one-size-fits-all treatment. This guide explains what HRT is, what it may help with, the main benefits and risks, and the factors that help determine whether it may be appropriate for you.

Book a menopause consultation Read more
In this guide

For many people with troublesome symptoms, HRT has a favourable benefit–risk balance after individual assessment. The important question is not whether HRT is universally “good” or “bad”, but whether the expected benefits outweigh the risks for you.

What is HRT?

Hormone replacement therapy (HRT) is a treatment used to manage symptoms associated with perimenopause and menopause. It works mainly by replacing oestrogen as levels fluctuate and fall. Depending on your circumstances, progesterone or another progestogen may also form part of the treatment.

HRT is not one single medicine. It is an umbrella term covering different hormones, routes and treatment schedules. That is why two people with similar symptoms may be prescribed different HRT plans.

You can discuss HRT while you are still having periods. You do not have to wait until menopause is complete or until symptoms become severe. Whether treatment is appropriate depends on the symptoms you want help with and your individual medical circumstances.

Which hormones are used in HRT?

  • Oestrogen

    Oestrogen is the main hormone used to relieve many menopause-associated symptoms. It can be taken as a tablet or delivered through the skin using a patch, gel or spray. Local vaginal oestrogen is used differently and acts mainly in vaginal and urinary tissues.

  • Progesterone or progestogen

    If you still have your womb and use systemic oestrogen, you will usually need progesterone or another progestogen as well. Its main role is to protect the womb lining from the effects of oestrogen. It may be prescribed separately or included in a combined HRT product.

What is the difference between systemic HRT and local vaginal treatment?

This distinction matters because the treatments have different jobs and different patterns of absorption.

Systemic HRT Local vaginal oestrogen
Where it acts Hormone circulates through the bloodstream and acts throughout the body. Applied in or around the vagina; only a small amount is absorbed systemically compared with systemic HRT.
Typical forms Tablets, patches, gels or sprays. Vaginal tablets/pessaries, creams, gels or rings, depending on the product.
Main role Wider menopause symptoms such as hot flushes and night sweats, with additional effects including bone protection while treatment is used. Vaginal dryness, soreness and some urinary symptoms linked with genitourinary syndrome of menopause.
Can they be used together? Sometimes. Yes, local treatment may be added when vaginal or urinary symptoms persist despite systemic HRT, where clinically appropriate.

What symptoms can HRT help?

HRT is most clearly used to treat menopause-associated symptoms. The amount of improvement varies from person to person, and not every symptom in midlife is caused by hormonal change.

  • Hot flushes and night sweats

    HRT is an effective treatment for vasomotor symptoms such as flushes and sweats.

  • Sleep disruption

    Sleep may improve when night sweats, temperature disturbance or other menopause symptoms are contributing.

  • Mood symptoms

    Low mood, anxiety or irritability associated with menopause may improve, although persistent or severe mental-health symptoms can have other causes and may need additional support.

  • Vaginal and urinary symptoms

    Systemic HRT may help some vaginal symptoms, but local vaginal treatment can be more targeted and may still be needed.

  • Other symptoms

    Some people report improvement in symptoms such as joint aches, headaches, concentration or sexual wellbeing, but these symptoms can have several causes and response should not be guaranteed.

What are the main benefits of HRT?

Relief of menopause-associated symptoms

For someone whose symptoms are affecting sleep, work, relationships, confidence or everyday functioning, symptom relief can be a meaningful clinical benefit in its own right. HRT does not need to be justified by a promise of wider “anti-ageing” or disease-prevention effects.

Bone health

Oestrogen has an important role in maintaining bone. HRT reduces bone loss and lowers fragility-fracture risk while it is being taken. This is especially relevant when menopause occurs early or prematurely, although individual advice is important.

Important distinction

HRT should not be started solely for the purpose of preventing cardiovascular disease or dementia. NICE recommends using HRT primarily for menopause-associated symptoms, with wider health outcomes discussed as part of individual shared decision-making.

Who may consider HRT?

HRT may be worth discussing if you have symptoms of perimenopause or menopause that are bothering you or affecting your quality of life. You can ask about treatment before your periods stop completely.

  • hot flushes, night sweats or temperature symptoms are disrupting daily life or sleep;
  • menopause-associated sleep or mood symptoms are difficult to manage;
  • you have a cluster of symptoms that appears to be related to perimenopause or menopause;
  • you have experienced premature or early menopause and need advice about symptom control and long-term bone health;
  • you are already considering HRT and want to understand the options and individual risks before deciding.

HRT is not automatically necessary for everyone who reaches menopause. Some people have few symptoms, prefer not to use hormones or have circumstances in which another treatment is more appropriate. The aim is informed choice, not persuading every person to take HRT.

Is HRT safe?

There is no single yes-or-no answer that applies to everyone. For many people with menopause symptoms, particularly those under 60 without major risk factors, the expected benefits are likely to outweigh the risks. But the benefit–risk balance changes according to the person and the treatment.

Current UK guidance emphasises shared decision-making: the type of HRT, route of administration, hormone combination, dose, duration, age and individual risk factors should all be considered.

  • Breast cancer

    Some types of combined HRT are associated with a small increase in breast-cancer risk, and risk is influenced by the hormone combination and duration. Oestrogen-only HRT has a different risk profile. This deserves an individual discussion rather than a single headline figure.

  • Blood clots

    Oral HRT increases the risk of venous blood clots. Transdermal HRT — patches, gels and sprays — does not show the same increase in VTE risk in NICE guidance.

  • Stroke

    Stroke risk differs by route, dose and age. Oral oestrogen is associated with an increase in stroke risk, while transdermal oestrogen is unlikely to increase stroke risk in NICE guidance.

  • Womb lining

    Using systemic oestrogen without adequate progestogenic protection can increase endometrial risk when the womb is present. This is why the progesterone/progestogen part of the plan matters.

  • Ovarian cancer

    NICE describes a very slight increase in ovarian-cancer risk with some HRT use. The absolute risk is low, but it can form part of an individual conversation.

  • Other health outcomes

    HRT is not prescribed as a general prevention treatment for heart disease or dementia. The evidence varies by outcome, age and HRT type.

What determines which HRT plan may suit you?

A menopause consultation should look at more than a symptom checklist. The plan needs to make sense clinically and practically.

  • Your symptoms

    Which symptoms are most troublesome, how long they have been present and how much they affect everyday life.

  • Menopause stage and bleeding

    Whether you are still having periods, when your last period was and whether bleeding has changed or become unexplained.

  • Whether you have a womb

    This affects whether progesterone or another progestogen is usually needed alongside systemic oestrogen.

  • Medical and family history

    Previous cancer, blood clots, cardiovascular disease, liver disease, migraine, blood pressure and other health factors can influence the route or whether specialist input is needed.

  • Current medicines and contraception

    Some medicines and hormonal contraceptives affect the options available and HRT itself is not reliable contraception.

  • Your preferences

    Some people prefer a tablet; others prefer transdermal treatment or want to avoid a patch. Practicality and adherence matter because treatment only works as intended if it can be used consistently.

When should I seek individual advice before starting HRT?

A complex history does not always mean HRT is impossible, but it does mean the decision should be individual rather than made from a checklist online. Ask for clinical advice if any of the following apply:

  • a personal history of breast cancer or another hormone-sensitive cancer;
  • a previous blood clot, clotting disorder, stroke, heart attack or significant cardiovascular disease;
  • current or recent liver disease;
  • untreated or poorly controlled high blood pressure;
  • unexplained vaginal bleeding, bleeding after sex or bleeding after menopause;
  • you are pregnant or think pregnancy may be possible;
  • you are considering starting systemic HRT later in life or a long time after menopause;
  • your medical history is complex, several risk factors apply, or you have previously been told HRT is not suitable and want that decision reviewed.

Bleeding should not be assumed to be “just hormones”

Unexplained bleeding should be assessed. If you are already using HRT, new, heavy, persistent or otherwise concerning bleeding also needs clinical review.

What happens after you start HRT?

Starting HRT is the beginning of a treatment process rather than the end of the conversation. Symptoms often improve gradually, and it can take time to find the route and regimen that works best for you.

A review is commonly recommended at around three months after starting or changing HRT, with regular review once treatment is stable. At review, your clinician may consider:

  • which symptoms have improved and which remain troublesome;
  • side effects and whether they are settling or affecting adherence;
  • bleeding pattern and any change that requires investigation;
  • whether the treatment route and routine are practical;
  • whether the oestrogen and progesterone/progestogen plan remains appropriate;
  • new medicines, diagnoses or changes in your wider health;
  • whether the benefits still outweigh the risks for you.

Do not change your HRT dose, add extra treatment or stop a prescribed progesterone/progestogen while continuing systemic oestrogen without clinical advice.

How do I choose between HRT options?

There is no single “best HRT”. Tablets, patches, gels and sprays all have practical and clinical differences, and some products contain oestrogen alone while others contain both oestrogen and progestogen. The right choice depends on the factors above rather than on which brand is most popular.

If you would like to compare the different ways HRT can be taken, read Types of HRT: Patches, Gels, Sprays & Tablets Compared. If a specific medicine is recommended for you, its LIVVE treatment page will explain that option in more detail, including how it is used and the product-specific information you need.

Frequently asked questions

Is HRT safe?

For many people with troublesome menopause symptoms, HRT has a favourable benefit–risk balance after individual assessment. Safety is not identical for everyone: age, medical history, the hormones used, route of treatment and duration all influence risk.

Should I take HRT?

There is no universal answer. HRT may be worth considering when menopause-associated symptoms are troublesome or affecting quality of life, but the decision should reflect your symptoms, menopause stage, medical history, bleeding history, treatment preferences and individual benefit–risk balance.

Can I take HRT during perimenopause?

Yes. You do not have to wait until your periods have stopped before discussing HRT. The treatment regimen may differ depending on whether you are still having periods and your bleeding pattern.

Do I need progesterone with HRT?

If you still have your womb and use systemic oestrogen, you will usually need progesterone or another progestogen to protect the womb lining. If you have had a total hysterectomy, oestrogen-only HRT is often used. Your clinician will confirm what applies to you.

What is the difference between systemic HRT and vaginal oestrogen?

Systemic HRT circulates through the body and is used for wider menopause symptoms. Vaginal oestrogen is applied locally for vaginal and urinary symptoms; only a small amount is absorbed into the bloodstream compared with systemic HRT.

Does HRT prevent osteoporosis?

HRT reduces bone loss and the risk of fragility fracture while it is being taken. This is particularly relevant in premature or early menopause, but bone health is only one part of the decision about treatment.

Does HRT prevent heart disease or dementia?

HRT should not be started solely to prevent cardiovascular disease or dementia. Its main role is treating menopause-associated symptoms, with other health effects discussed as part of an individual benefit–risk conversation.

How long can I stay on HRT?

There is no single fixed duration that is right for everyone. Treatment should be reviewed regularly, with the decision to continue based on symptoms, benefits, risks and any changes in health.

Is HRT contraception?

No. Standard HRT does not reliably prevent pregnancy. If contraception is still needed, discuss which options can be used alongside HRT.

What if HRT is not suitable for me?

HRT is not the only way to manage menopause symptoms. Depending on your symptoms and medical history, non-hormonal medicines, menopause-specific CBT, local vaginal treatments and lifestyle measures may all have a role.

Ready to understand your HRT options?

A LIVVE clinician can review your symptoms, bleeding history, medical history and preferences, explain the benefits and risks that apply to you and discuss whether HRT or another option may be appropriate.

Book menopause assessment

Medical Disclaimer

This article provides general information and does not replace individual medical advice. HRT route and regimen should be selected after clinical assessment. Do not change dose, route or progesterone/progestogen treatment without advice. If you are unsure about your treatment, contact LIVVE for guidance.

Hormone Health Consultation

Hormone Health Consultation

£75 · Personalised advice

Book Now - £75